Document ID: chunk:federal_register_of_legislation:F2024C00880:front:0:p1
Version: federal_register_of_legislation:F2024C00880
Segment Type: other
Provision Reference: 
Character Range: 0–3079

National Health (Growth Hormone Program) Special Arrangement 2015

PB 85 of 2015
made under subsections 100(1) and (2) of the

National Health Act 1953

Compilation No. 21

Compilation date: 1 October 2024

                Includes amendments: F2024L01245
About this compilation

This compilation

This is a compilation of the National Health (Growth Hormone Program) Special Arrangement 2015 that shows the text of the law as amended and in force on 1 October 2024 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents
Part 1—Preliminary
1 Name of Special Arrangement
4 Definitions
Part 2—Pharmaceutical benefits covered by this Special Arrangement
Division 1—General
5 Pharmaceutical benefits covered by this Special Arrangement
6 Application of Part VII of the Act
7 Section 100 only supply
Division 2—Prescriptions for pharmaceutical benefits
Subdivision A—Prescriptions for children
7A Prescription of pharmaceutical benefits in Part 1 of Schedule 1 for children
8 Prescription for child—maximum quantity
9 Prescription for child—maximum number of repeats
Subdivision B—Prescriptions for adults
9AA Prescription of pharmaceutical benefits in Part 2 of Schedule 1 for adults
9AB Prescription for adult—maximum quantity
9AC Prescription for adult—maximum number of repeats
Subdivision C—Prescriptions for children and adults
9AD Prescription by authorised prescriber only
Part 3—Treatment doses for children
Division 1—General
9B This Part applies to children
10 Definitions relating to doses of somatropin
11 Assessment of dosage of pharmaceutical benefit
Division 2—Reclassification
12 Dose for change of treatment